The sounds of silence: Synonymous mutations affect functions

Pharmacogenomics

Volumn 8, Issue 6, 2007, Pages 527-532

  Sauna, Zuben E ^a   Kimchi Sarfaty, Chava ^b   Ambudkar, Suresh V ^a   Gottesman, Michael M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CATECHOL METHYLTRANSFERASE; CATECHOLAMINE; CHLORAMPHENICOL ACETYLTRANSFERASE; CYCLOSPORIN A; GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; PYRUVATE KINASE; VERAPAMIL;

ALTERNATIVE RNA SPLICING; CODON; DRUG TRANSPORT; EDITORIAL; EVIDENCE BASED MEDICINE; GENETIC CODE; GENETIC SELECTION; GENETIC STABILITY; GENETIC VARIABILITY; HAPLOTYPE MAP; INDIVIDUALIZATION; MUTATIONAL ANALYSIS; NOCICEPTION; NUCLEIC ACID BASE SUBSTITUTION; PHARMACOGENOMICS; PHENOTYPIC VARIATION; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; RNA STABILITY; RNA STRUCTURE; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT PLANNING;

ANIMALS; GENE SILENCING; HUMANS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 34250639871     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.8.6.527     Document Type: Editorial

References (41)

1. Anfinsen CB: Principles that govern folding of protein chains. Science 181, 223-230 (1973).
2. Kimura M: Preponderance of synonymous changes as evidence for the neutral theory of molecular evolution. Nature 267, 275-276 (1977).
3. Dittmar KA, Goodenbour JM, Pan T: Tissue-specific differences in human transfer RNA expression. PLoS Genet. 2, 2107-2115 (2006).
4. Gouy M, Gautier C: Codon usage in bacteria: correlation with gene expressivity. Nucl. Acids Res. 10, 7055-7074 (1982).
5. Duret L: tRNA gene number and codon usage in the C. elegans genome are co-adapted for optimal translation of highly expressed genes. Trends Genet. 16, 287-289 (2000).
6. Ikemura T: Codon usage and tRNA content in unicellular and multicellular organisms. Mol. Biol. Evol. 2, 13-34 (1985).
7. Moriyama EI, Powell JR: Codon usage bias and tRNA abundance in Drosophila. J Mol. Evol. 45, 514-523 (1997).
8. Duret L: Evolution of synonymous codon usage in metazoans. Curr. Opin. Genet. Dev. 12, 640-649 (2002).
9. Chamary JV, Parmiey JL, Hurst LD: Hearing silence: non-neutral evolution at synonymous sites in mammals. Nat. Rev. Genet. 7, 98-108 (2006).
10. Cartegni L, Chew SL, Krainer AR: Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat. Rev. Genet. 3, 285-298 (2002).
11. Stoletzki N, Eyre-Walker A: Synonymous codon usage in Esherichia coli. selection for translational accuracy. Mol. Biol. Evol. 24, 374-381 (2007).
12. Kimchi-Sarfaty C, Oh JM, Kim IW et al.: A 'silent' polymorphism in the MDR1 gene changes substrate specificity. Science 315. 525-528 (2007).
13. Nackley AG, Shabalina SA, Tchivileva IE et al.: Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 314. 1930-1933 (2006).
14. Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, Gottesman MM: P-glycoprotein: from genomics to mechanism. Oncogene 22, 7468-7485 (2003).
15. Penzotti JE, Landrum GA, Putta S: Building predictive ADMET models for early decisions in drug discovery. Curr. Opin. Drug Discov Dev. 7, 49-61 (2004).
16. Kerb R: Implications of genetic polymorphisms in drug transporters for pharmacotherapy. Cancer Lett. 234, 4-33 (2006).
17. Pauli-Magnus C, Kroetz DL: Functional implications of genetic polymorphisms in the multidrug resistance gene MDR1 (ABCB1). Pharm. Res. 21, 904-913 (2004).
18. Kimchi-Sarfaty C, Marple AH, Shinar S et al.: Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene. Pharmacogenomics 8, 29-39 (2007).
19. Kiho Y. Rich A: Induced enzyme formed on bacterial polyribosomes. Proc. Natl. Acad. Sci. USA 51, 111-118 (1964).
20. Fedorov AN, Baldwin TO: Contribution of cotranslational folding to the rate of formation of native protein structure. Proc. Natl. Acad. Sci. USA 92, 1227-1231 (1995).
21. Fedorov AN, Baldwin TO: Cotranslational protein folding. J. Biol. Chem. 272, 32715-32718 (1997).
22. Batey S, Scott KA, Clarke J: Complex folding kinetics of a multidomain protein. Biophys. J. 90, 2120-2130 (2006).
23. Kowarik M, Kung S, Martoglio, B, Helenius A: Protein folding during cotranslational translocation in the endoplasmic reticulum. Mol. Cell 10, 769-778 (2002).
24. Purvis IJ, Bettany AJ, Santiago TC et al.: The efficiency of folding of some proteins is increased by controlled rates of translation in vivo: a hypothesis. J. Mol. Biol. 193, 413-417 (1987).
25. Komar AA, Lesnik T. Reiss C: Synonymous codon substitutions affect ribosome traffic and protein folding during in vitro translation. FEBS Lett, 462, 387-391 (1999).
26. Bukau B, Weissman J, Horwich A: Molecular chaperones and protein quality control. Cell 125, 443-451 (2006).
27. Sauna ZE, Ambudkar SV: About a switch: how P-glycoprotein (ABCB1) harnesses the energy of ATP binding and hydrolysis to do mechanical work. Mol. Cancer Ther. 6, 13-23 (2007).
28. Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM: Biochemical, cellular. and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 39, 361-398 (1999).
29. Makeyev EV, Kolb VA, Spirin AS: Enzymatic activity of the ribosome-bound nascent polypeptide. FEBS Lett. 378, 166-170 (1996).
30. Reiss C, Ehrlich R, Lesnick T. Parvez S, Parvez H: Conformational diseases: misfolding mechanisms may pave the way to early therapy. Neurotoxicol. Teratol. 24, ix-xiv (2002).
31. Clarke DT, Doig AJ, Stapley BJ, Jones GR: The α-helix folds on the millisecond time scale. Proc. Natl. Acad Sci. USA 96, 7232-7237 (1999).
32. Gustafsson C, Govindarajan S, Minshull J: Codon bias and heterologous protein expression. Trends Biotechnol. 22, 346-353 (2004).
33. Villalobos A. Ness JE, Gustafsson C, Minshull J, Govindarajan S: Gene Designer: a synthetic biology tool for constructing artificial DNA segments. BMC Bioinformatics 7, 285 (2006).
34. Tian J, Gong H, Sheng N et al.: Accurate multiplex gene synthesis from programmable DNA microchips. Nature 432, 1050-1054 (2004).
35. The International HapMap Consortium: A haplotype map of the human genome. Nature 437, 1299-1320 (2005).
36. Collins FJ: Personalized medicine: a new approach to staying well. The Boston Globe 17th July (2005).
37. Lee J-E, Choi JH, Lee JH. Lee MG: Gene SNPs and mutations in clinical genetic testing: haplotype-based testing and analysis. Mutat Res. 573, 195-204 (2005).
38. Jegga AG, Gowrisankar S, Chen J, Aronow BJ: PolyDoms: a whole genome database for the identification of non-synonymous coding SNPs with the potential to impact disease. Nucl. Acids Res. 35, D700-D706 (2007).
39. Tan EK, Chan DK, Ng PW et al.: Effect of MDR1 haplotype on risk of Parkinson disease. Arch. Neurol. 62, 460-464 (2005).
40. Potocnik U, Ferkoij I, Glavac D, Dean M: Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitts. Genes Immun. 5, 530-539 (2004).
41. Johne A. Kopke K, Gerloff T et al.: Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene. Clin. Pharmacol. Ther. 72, 584-594 (2002).